Cipher Pharmaceuticals is a Canadian specialty pharmaceutical firm that offers commercial and early to late-stage products. The company acquires products that can serve unmet medical needs, develops them clinically, and gains regulatory approval for them. Cipher currently markets these products in Canada, the U.S., and South America, either directly or indirectly via partners.